Jun Yang1, Xiaofeng Zhao1, Archana Patel2, Rachana Potru2, Sadra Azizi-Ghannad2, Michael Dolinger2, James Cao3, Catherine Bartholomew2, Joseph Mazurkiewicz4, David Conti5, David Jones6, Yunfei Huang4, Xinjun Cindy Zhu7. 1. Department of Medicine, Division of Gastroenterology and Hepatology, Albany Medical College, Albany, New York; Center of Cardiovascular Sciences, Albany Medical College, Albany, New York. 2. Department of Medicine, Division of Gastroenterology and Hepatology, Albany Medical College, Albany, New York. 3. Center of Cardiovascular Sciences, Albany Medical College, Albany, New York. 4. Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York. 5. Department of Transplant Surgery, Albany Medical College, Albany, New York. 6. Department of Pathology, Albany Medical College, Albany, New York. 7. Department of Medicine, Division of Gastroenterology and Hepatology, Albany Medical College, Albany, New York; Center of Cardiovascular Sciences, Albany Medical College, Albany, New York. Electronic address: zhux@mail.amc.edu.
Abstract
BACKGROUND & AIMS: The immunosuppressant rapamycin frequently causes noninfectious diarrhea in organ transplant recipients. We investigated the mechanisms of this process. METHODS: We performed a retrospective analysis of renal transplant recipients treated with rapamycin from 2003 through 2010 at Albany Medical College, collecting data on serum levels of rapamycin. Levels of the Na+/H+ exchanger 3 (NHE3) were measured in human ileal biopsy specimens from patients who did and did not receive rapamycin (controls), in ileum tissues from rats or mice given rapamycin, and in mice with intestine-specific disruption of mammalian target of rapamycin (Mtor) (mTOR(f/f):Villin-cre mice) or Atg7 (Atg7(flox/flox); Villin-Cre). Exchange activity and intestinal water absorption were measured using a pH-sensitive dye and small intestine perfusion, respectively. RESULTS: Episodes of noninfectious diarrhea occurred in organ recipients after increases in serum levels of rapamycin. The expression of NHE3 was reduced in the ileal brush border of patients with diarrhea. In rats and mice, continuous administration of low doses of rapamycin reduced levels of NHE3 in intestinal tissues; this effect was not observed in mice with intestinal deletion of ATG7, indicating that autophagy is required for the reduction. Administration of single high doses of rapamycin to mice, to model the spikes in rapamycin levels that occur in patients with severe diarrheal episodes, resulted in reduced phosphorylation of S6 and AKT in ileal tissues, indicating inhibition of the mTOR complex (mTORC1 and mTORC2). The intestines of mice with intestine-specific deletion of mTOR were dilated and contained large amounts of liquid stools; they also had reduced levels of total NHE3 and NHERF1 compared with control mice. We observed a significant reduction in Na(+)/H(+) exchange activity in ileum tissues from these mice. CONCLUSIONS: Rapamycin inhibition of mTOR reduces levels of NHE3 and Na(+)/H(+) exchange activity in intestinal tissues of patients and rodents. This process appears to require the autophagic activity mediated by ATG7. Loss of mTOR regulation of NHE3 could mediate the development of diarrhea in patients undergoing rapamycin therapy.
BACKGROUND & AIMS: The immunosuppressant rapamycin frequently causes noninfectious diarrhea in organ transplant recipients. We investigated the mechanisms of this process. METHODS: We performed a retrospective analysis of renal transplant recipients treated with rapamycin from 2003 through 2010 at Albany Medical College, collecting data on serum levels of rapamycin. Levels of the Na+/H+ exchanger 3 (NHE3) were measured in human ileal biopsy specimens from patients who did and did not receive rapamycin (controls), in ileum tissues from rats or mice given rapamycin, and in mice with intestine-specific disruption of mammalian target of rapamycin (Mtor) (mTOR(f/f):Villin-cre mice) or Atg7 (Atg7(flox/flox); Villin-Cre). Exchange activity and intestinal water absorption were measured using a pH-sensitive dye and small intestine perfusion, respectively. RESULTS: Episodes of noninfectious diarrhea occurred in organ recipients after increases in serum levels of rapamycin. The expression of NHE3 was reduced in the ileal brush border of patients with diarrhea. In rats and mice, continuous administration of low doses of rapamycin reduced levels of NHE3 in intestinal tissues; this effect was not observed in mice with intestinal deletion of ATG7, indicating that autophagy is required for the reduction. Administration of single high doses of rapamycin to mice, to model the spikes in rapamycin levels that occur in patients with severe diarrheal episodes, resulted in reduced phosphorylation of S6 and AKT in ileal tissues, indicating inhibition of the mTOR complex (mTORC1 and mTORC2). The intestines of mice with intestine-specific deletion of mTOR were dilated and contained large amounts of liquid stools; they also had reduced levels of total NHE3 and NHERF1 compared with control mice. We observed a significant reduction in Na(+)/H(+) exchange activity in ileum tissues from these mice. CONCLUSIONS:Rapamycin inhibition of mTOR reduces levels of NHE3 and Na(+)/H(+) exchange activity in intestinal tissues of patients and rodents. This process appears to require the autophagic activity mediated by ATG7. Loss of mTOR regulation of NHE3 could mediate the development of diarrhea in patients undergoing rapamycin therapy.
Authors: Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini Journal: Mol Cell Date: 2006-04-06 Impact factor: 17.970
Authors: Rakhilya Murtazina; Olga Kovbasnjuk; Nicholas C Zachos; Xuhang Li; Yueping Chen; Ann Hubbard; Boris M Hogema; Deborah Steplock; Ursula Seidler; Kazi M Hoque; Chung Ming Tse; Hugo R De Jonge; Edward J Weinman; M Donowitz Journal: J Biol Chem Date: 2007-06-19 Impact factor: 5.157
Authors: Ömer H Yilmaz; Pekka Katajisto; Dudley W Lamming; Yetis Gültekin; Khristian E Bauer-Rowe; Shomit Sengupta; Kivanc Birsoy; Abdulmetin Dursun; V Onur Yilmaz; Martin Selig; G Petur Nielsen; Mari Mino-Kenudson; Lawrence R Zukerberg; Atul K Bhan; Vikram Deshpande; David M Sabatini Journal: Nature Date: 2012-06-28 Impact factor: 49.962
Authors: Georg F Vogel; Jorik M van Rijn; Iris M Krainer; Andreas R Janecke; Carsten Posovszky; Marta Cohen; Claire Searle; Prevost Jantchou; Johanna C Escher; Natalie Patey; Ernest Cutz; Thomas Müller; Sabine Middendorp; Michael W Hess; Lukas A Huber Journal: JCI Insight Date: 2017-07-20
Authors: Lauren Barron; Raphael C Sun; Bola Aladegbami; Christopher R Erwin; Brad W Warner; Jun Guo Journal: Cell Mol Gastroenterol Hepatol Date: 2016-12-10
Authors: Ana Patrícia de Oliveira; André Luis Fernandes Lopes; Gabriella Pacheco; Isabela Ribeiro de Sá Guimarães Nolêto; Lucas Antonio Duarte Nicolau; Jand Venes Rolim Medeiros Journal: Med Hypotheses Date: 2020-09-02 Impact factor: 1.538
Authors: Hong-Yan Du; Rong Wang; Jian-Liang Li; Huang Luo; Xiao-Yan Xie; Ran Yan; Yue-Ling Jian; Jin-Ying Cai Journal: Mol Vis Date: 2021-12-12 Impact factor: 2.367
Authors: Georg F Vogel; Katharina M C Klee; Andreas R Janecke; Thomas Müller; Michael W Hess; Lukas A Huber Journal: J Cell Biol Date: 2015-11-09 Impact factor: 10.539